|
|
Relationship between chronic diseases and benign prostatic hyperplasia in middle-aged and older Chinese adults: A cross-sectional study based on CHARLS database
Ming Jie, Jin Song, Liu Zhanliang, Wang Zongwei, Niu Yinong
Journal of Capital Medical University
2025, 46 (2):
252-262.
DOI: 10.3969/j.issn.1006-7795.2025.02.011
Objective To explore the correlation between chronic diseases and the risk of benign prostatic hyperplasia (BPH) in middle-aged and older Chinese man.Methods Data from the 2013 China Health and Retirement Longitudinal Study (CHARLS) were used, including 4 509 male participants aged 45 years and older. Chronic diseases and BPH diagnoses were obtained through a questionnaire survey. Logistic regression analysis was performed to identify independent risk factors for BPH. Restricted cubic splines (RCS) were used to explore the nonlinear relationship between variables and BPH prevalence, while stratified analyses were conducted to assess the differential impact of chronic diseases on BPH prevalence in different subgroups.Results Compared to patients without BPH, those with BPH had a significantly higher prevalence of comorbid chronic diseases, including hypertension, diabetes, chronic respiratory diseases, chronic heart disease, stroke, chronic kidney disease, chronic digestive diseases, arthritis or rheumatism, depression, and memory-related disorders. Multivariable Logistic regression analysis indicated that factors such as the 10-item Center for Epidemiological Studies Depression Scale (CESD-10) scores (OR = 1.043, 95% CI: 1.022-1.063, P < 0.001), chronic respiratory disease (OR = 1.518, 95% CI: 1.143-1.998, P = 0.003), chronic heart disease (OR = 1.515, 95% CI: 1.143-1.998, P = 0.003), chronic kidney disease (OR = 2.384, 95% CI: 1.799-3.137, P < 0.001), and chronic digestive disease (OR=1.427, 95%CI:1.129-1.796,P=0.003) were independently associated with the occurrence of BPH. RCS analysis demonstrated no non-linear association between age, BMI, and CESD-10 scores and BPH. Stratified analysis revealed that the influence of these chronic conditions on BPH remained constantly stable across different subgroups.Conclusion BPH is commonly comorbid with various chronic diseases. Future treatment strategies for BPH should consider the shared pathological mechanisms between BPH and these chronic conditions, with a focus on integrated interventions targeting common pathways.
Reference |
Related Articles |
Metrics
|
|